Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Salter

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Diabetes|December 2, 1999
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsM Feili-Hariri, X Dong, S M Alber, et al.
Nature|March 23, 1989
Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8R D Salter, A M Norment, B P Chen, et al.
European Journal of Immunology|November 1, 1996
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytesM J Maeurer, H W Chan, J Karbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2W J Storkus, R D Salter, J Alexander, et al.
Human Immunology|February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2H J Zeh, G H Leder, M T Lotze, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Nature of polymorphism in HLA-A, -B, and -C moleculesP Parham, C E Lomen, D A Lawlor, et al.
Nature|May 3, 1990
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2R D Salter, R J Benjamin, P K Wesley, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Diabetes|December 2, 1999
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsM Feili-Hariri, X Dong, S M Alber, et al.
Nature|March 23, 1989
Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8R D Salter, A M Norment, B P Chen, et al.
European Journal of Immunology|November 1, 1996
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytesM J Maeurer, H W Chan, J Karbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2W J Storkus, R D Salter, J Alexander, et al.
Human Immunology|February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2H J Zeh, G H Leder, M T Lotze, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Nature of polymorphism in HLA-A, -B, and -C moleculesP Parham, C E Lomen, D A Lawlor, et al.
Nature|May 3, 1990
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2R D Salter, R J Benjamin, P K Wesley, et al.
Pageof 4